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The pharmacological treatment of major psychiatric dis-
orders is based on antipsychotic medication (for schizo-
phrenia and manic episodes of mood disorders) and on
antidepressants (for the depressive episodes of mood dis-
orders). The main pharmacotherapeutic considerations
concern efficacy, side-effects and tolerability. These issues
are related to pharmacodynamic and pharmacokinetic
characteristics of the various medications such as the
affinity to various receptors, selectivity to those which are
most relevant in the pathophysiology of the disorders,
and drug half life. These qualities are associated to the
optimum daily dosing, dose regimen and the mode of
escalation of the doses of each drug, as well as to its side-
effect profile. These issues will be discussed for antipsy-
chotics and antidepressants, in a practical manner,
together with general issues in pharmacotherapy related
to polypharmacy and combinations with other drug
classes, whenever this is appropriate.
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